These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

316 related articles for article (PubMed ID: 2175072)

  • 1. [Cerebrovascular disorders associated with livedo (Sneddon's syndrome): its relation to lupus anticoagulant].
    Kalashnikova LA; Prudnikova LZ; Nasonov EP
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1990; 90(7):104-7. PubMed ID: 2175072
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Sneddon syndrome: cardiac pathology and anti-phospholipid antibodies].
    Kalashnikova LA; Nasonov EL; Borisenko VV; Isman VB; Kushekbaeva AE; Kovalev VIu; Prudnikova LZ
    Klin Med (Mosk); 1990 Jun; 68(6):37-41. PubMed ID: 2214636
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Livedo reticularis, cerebrovascular disorders and mitral disease: a new cause of Sneddon's syndrome?].
    Vaillant L; Larmande P; Arbeille B; Desveaux B; Gruel Y; Lorette G
    Ann Dermatol Venereol; 1990; 117(12):925-30. PubMed ID: 2082786
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Sneddon's syndrome: its clinical characteristics and etiopathogenic factors].
    Sempere AP; Martínez B; Bermejo F; Tahoces ML; Cabello A
    Rev Clin Esp; 1992 Jun; 191(1):3-7. PubMed ID: 1631358
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sneddon's syndrome: an antiphospholipid antibody syndrome?
    Levine SR; Langer SL; Albers JW; Welch KM
    Neurology; 1988 May; 38(5):798-800. PubMed ID: 3129674
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IgG reactivity to phospholipid-bound beta(2)-glycoprotein I is the main determinant of the fraction of lupus anticoagulant activity quenched by addition of hexagonal (II) phase phospholipid in patients with the clinical suspicion of antiphospholipid-antibody syndrome.
    Safa O; Crippa L; Della Valle P; Sabbadini MG; Viganò D'Angelo S; D'Angelo A
    Haematologica; 1999 Sep; 84(9):829-38. PubMed ID: 10477458
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anticardiolipin antibodies in Sneddon's syndrome.
    Kalashnikova LA; Nasonov EL; Kushekbaeva AE; Gracheva LA
    Neurology; 1990 Mar; 40(3 Pt 1):464-7. PubMed ID: 2314589
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Sneddon's syndrome and the primary antiphospholipid syndrome].
    Kalashnikova LA; Nasonov EL; Stoianovich LZ; Kovalev VIu; Kosheleva NM; Reshetniak TM
    Ter Arkh; 1993; 65(3):64-70. PubMed ID: 8059389
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Study of antiphospholipid antibodies in a patient with Sneddon's syndrome and her family.
    Lousa M; Sastre JL; Cancelas JA; Gobernado JM; Pardo A
    Stroke; 1994 May; 25(5):1071-4. PubMed ID: 8165682
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Classification of Sneddon's syndrome.
    Schellong SM; Weissenborn K; Niedermeyer J; Wollenhaupt J; Sosada M; Ehrenheim C; Lubach D
    Vasa; 1997 Aug; 26(3):215-21. PubMed ID: 9286155
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sneddon's syndrome: cardiac pathology and antiphospholipid antibodies.
    Kalashnikova LA; Nasonov EL; Borisenko VV; Usman VB; Prudnikova LZ; Kovaljov VU; Kushekbaeva AF
    Clin Exp Rheumatol; 1991; 9(4):357-61. PubMed ID: 1934683
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The antiphospholipid antibody syndrome: its pathogenesis and clinico-morphological manifestations].
    Zerbino DD; Lukasevich LL; Bilynskaia OA
    Arkh Patol; 1990; 52(4):65-9. PubMed ID: 2117434
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Livedo reticularis and cerebrovascular accidents (Sneddon's syndrome) as a clinical expression of antiphospholipid syndrome.
    Gantcheva M; Tsankov N
    J Eur Acad Dermatol Venereol; 1999 Mar; 12(2):157-60. PubMed ID: 10343946
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Primary antiphospholipid syndrome: study of 27 patients].
    Barquinero J; Ordi J; Vilardell M; Jordana R; Tolosa C; Selva A; Monasterio Y
    Med Clin (Barc); 1990 Jan; 94(2):41-5. PubMed ID: 2109812
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Anti-beta 2 glycoprotein 1 antibodies in idiopathic livedo reticularis].
    Aubry F; Crickx B; Nicaise P; Labarre C; Viard JP; Belaïch S
    Ann Dermatol Venereol; 1995; 122(10):667-70. PubMed ID: 8687049
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical value of determining the levels of lupus anticoagulant and anti-cardiolipin antibodies].
    Alekberova ZS; Nasonov EL; Prudnikova LZ; Aleksandrova LZ; Kurdiashova VF
    Ter Arkh; 1988; 60(7):84-7. PubMed ID: 3145584
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical manifestations associated with the presence of lupus anticoagulant].
    Miori L; Bellosta M; Miori E; Rabbiosi G
    G Ital Dermatol Venereol; 1989 Mar; 124(3):107-10. PubMed ID: 2509330
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Sneddon syndrome as a clinical manifestation of the antiphospholipid antibody syndrome].
    Mojzes J; Battyáni Z; Grexa E
    Orv Hetil; 1993 Jan; 134(5):251-5. PubMed ID: 8426732
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antiphospholipid antibodies.
    Levine SR; Welch KM
    Ann Neurol; 1989 Sep; 26(3):386-9. PubMed ID: 2508536
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Sneddon syndrome with detection of anti-phospholipid antibodies].
    Wand A; Jünger H
    Hautarzt; 1992 Jun; 43(6):380-2. PubMed ID: 1628973
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.